When was PickCells founded?

PickCells was founded in 2014 and raised its 1st funding round 8 years after it was founded.

Where is PickCells located?

PickCells is headquartered in Recife, Brazil.

How many employees does PickCells have?

As of Aug 31, 2026, the latest employee count at PickCells is 2.

Is PickCells a funded company?

PickCells is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jun 22, 2022.

When was the latest funding round of PickCells?

PickCells' latest funding was a $***** Seed round on Jun 22, 2022, with participation from 1 investor.

Where does PickCells rank among its competitors?

PickCells ranks 162nd amongst 218 active competitors, of which 56 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Techcyte, which secured $15M in Apr, 2026.

Who are the top competitors of PickCells?

PickCells' top competitors include PathAI, Deciphex and Aignostics. Among them, Techcyte secured the most recent funding round in April, 2026.

PickCells - 2026 Company Profile, Team, Funding & Competitors

PickCells is a seed company based in Recife (Brazil), founded in 2014 by Paulo Melo and Andre Caetano. It operates as an AI and cloud-based pathology image analysis tool. PickCells has raised an undisclosed amount in funding. The company has 218 active competitors, including 56 funded and 13 that have exited. Its top competitors include companies like PathAI, Deciphex and Aignostics.

Company Details

AI and cloud-based pathology image analysis tool. The company has developed software that assists with cell analysis for pathological tests. It has features for image analysis, visualization, data storage, and more.

Website: pickcells.bio
Email ID: *****@pickcells.bio
Phone Number: +55 **********

Key Metrics

Founded Year

2014

Location

Recife, Brazil

Stage

Seed

Latest Funding Round

Seed, Jun 22, 2022, $*****

Investors

Sabin

Ranked

162^nd among 218 active competitors

Employee Count

2 as on Aug 31, 2026

Similar Companies

PathAI & 249 more

View PickCells' full profile

PickCells has raised funding over 1 round. Its latest funding round was a Seed round on Jun 22, 2022 for $*****. 1 investor participated in its latest round. PickCells has 1 institutional investor.

Here is the list of recent funding rounds of PickCells:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 22, 2022	4576190	Seed	6154214	2733571	2887195	1125951

Access funding benchmarks and valuations. Sign up today!

View details of PickCells's funding rounds and investors

The founders of PickCells are Paulo Melo and Andre Caetano.

Here are the details of PickCells' key team members:

Paulo Melo: Co-Founder of PickCells.
Contact Info: 1 email address
Andre Caetano: Co-Founder of PickCells.

View details of PickCells's Founder profiles and Board Members

PickCells' employee count trend

PickCells has 2 employees as of Aug 26. Here is PickCells's employee count trend over the years:

Uncover PickCells' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PickCells include PathAI, Deciphex and Aignostics. Here is the list of Top 10 competitors of PickCells, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	71/100
2nd	Deciphex 2017, Dublin (Ireland), Series C	Network of pathologists providing digital diagnostic services for medical testing	$56.6M	Seroba Life Sciences, Molten Ventures & 13 others	65/100
3rd	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
4th	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	64/100
5th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
6th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	62/100
7th	Median Technologies 2002, Valbonne (France), Public	Developer of medical imaging software for clinical trials and diagnostics	$5.28M	Matignon Finances, Lion Point Life Science Partners ... & 13 others	61/100
8th	Visiopharm 2001, Horsholm (Denmark), Acquired	Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization	$26.3M	BankInvest, Vaekstfonden & 4 others	60/100
9th	Quibim 2015, Valencia (Spain), Series A	Developer of medical imaging software for radiomics and biomarker analysis	$60M	Asabys Partners, Adara & 20 others	59/100
10th	HistoIndex 2010, Singapore (Singapore), Series A	Provider of AI powered digital pathology platform for fibrosis analysis	$6.89M	OCBC, SEEDS Capital & 2 others	57/100
162nd	PickCells 2014, Recife (Brazil), Seed	AI and cloud-based pathology image analysis tool	-	Sabin	21/100